Literature DB >> 6303209

Comparative efficacy of cefmenoxime versus penicillin in the treatment of gonorrhea.

S R Obaid, M Y Khan, M L Simpson, R P Gruninger, D I Wigren.   

Abstract

A total of 121 men with complicated infections caused by beta-lactamase-negative Neisseria gonorrhoeae were included in this study. They were randomly assigned to regimens of either cefmenoxime (1.0 g) or procaine penicillin G (4.8 X 10(6) U) intramuscularly. Only the penicillin group also took 1.0 g of probenecid orally. A total of 99 patients completed the study, providing data from 108 infected sites. In the cefmenoxime group, there were 49 urethral, 1 rectal, and 2 pharyngeal infections; in the penicillin group, there were 49 urethral, 4 rectal, and 3 pharyngeal infections. In the cefmenoxime group, all except one urethral infection were eradicated. This patient admitted having had sexual intercourse during the follow-up period and was considered to be reinfected. In the penicillin group, all except one pharyngeal infection were cured. No adverse reactions were noted in either group. In this study, cefmenoxime was as effective as penicillin in the treatment of gonococcal urethritis in men.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303209      PMCID: PMC184649          DOI: 10.1128/AAC.23.3.349

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae.

Authors:  P R Murray; J L Christman; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

2.  In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.

Authors:  C Thornsberry; C N Baker; R N Jones
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

3.  Clinical experience in the use of cefuroxime in gonorrhoea.

Authors:  W Fowler; G Rahim; J D Brown
Journal:  Br J Vener Dis       Date:  1978-12

4.  Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.

Authors:  H H Handsfield; V L Murphy; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

5.  Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.

Authors:  M Y Khan; Y Siddiqui; M L Simpson; R P Gruninger
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae.

Authors:  T T Yoshikawa; S A Shibata; P Herbert; P A Oill
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

  6 in total
  2 in total

Review 1.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.